# Heparin Sodium

NDC: 0641-6199
Generic name: Heparin sodium
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20190518

FDA application: NDA017037

## Active ingredients

- HEPARIN SODIUM: 5000 [USP'U]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0641-6199"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0641-6199
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7014808d-cec9-4b2c-8eb5-940493e356ab